Skip to content
You can now search across every topic, entity and event.What's new
Pandemics and Biosecurity
16JUN

An animal microbe goes person to person

2 min read
10:26UTC

ECDC's 17 June risk assessment confirmed 97 cases of Dermatophilus congolensis across six European countries and judged human-to-human spread the most likely route, though the disease stays mild.

ScienceDeveloping
Key takeaway

A once animal-only bacterium is now judged to spread between people in Europe, though it stays mild.

The European Centre for Disease Prevention and Control (ECDC) published a rapid risk assessment on Wednesday 17 June confirming 97 cases of Dermatophilus congolensis across six countries, including new cases in Norway and Austria 1. Dermatophilus congolensis is a gram-positive bacterium that causes Dermatophilosis, a skin infection traditionally seen in livestock; a rapid risk assessment is the standard tool ECDC issues to grade an emerging threat for EU member states. The agency judged human-to-human spread through close contact the most likely transmission route, while rating the disease itself mild, antibiotic-responsive, and the risk to the population very low.

Dermatophilus congolensis is an animal-associated organism now assessed as moving between people, and ECDC's reading has escalated step by step: from the 5 June ECDC notice of 50 European sauna-linked cases , through the peer-reviewed documentation of sexual transmission published in June , to a count that has now nearly doubled and a formal verdict that person-to-person spread is the leading explanation. A pathogen that establishes a human transmission route, even a mild one, is the kind of signal surveillance exists to catch early, before the route widens. The mild presentation is reassuring for any individual patient; the route is what warrants the watch.

Deep Analysis

In plain English

Dermatophilus congolensis is a bacterium that normally infects animals, particularly horses, cattle and sheep, causing a crusty skin disease called rain scald or mud fever. It very rarely affects people. In 2025-2026, ECDC has confirmed that it has been spreading among people in Europe through close skin contact, particularly in places like saunas and certain social settings. As of 17 June 2026, there are 97 confirmed cases in six European countries: France, Germany, Spain, Sweden, Norway and Austria. The disease causes mild skin lesions and responds well to standard antibiotics. ECDC rates the risk to the general public as very low. This is a surveillance story: scientists tracking a zoonotic bacterium establishing new person-to-person spread for the first time, rather than an immediate public health emergency.

What could happen next?
  • Precedent

    The Dermatophilus congolensis case count doubling from 50 to 97 in 12 days likely reflects reporting improvement after the 5 June ECDC notice rather than true incidence acceleration, illustrating how surveillance signals can amplify apparent outbreak speed.

First Reported In

Update #8 · Ebola reaches France through a screening blind spot

European Centre for Disease Prevention and Control· 25 Jun 2026
Read original
Different Perspectives
Chinese health authorities
Chinese health authorities
China reported three human H9N2 cases to WHO between 10 and 16 July: two four-year-olds recovered, a 44-year-old man remains in intensive care, the first severity signal in a cluster that has produced 173 cases and 2 deaths globally since 2015. The subtype is distinct from the H5N1 series this topic otherwise tracks.
US public health authorities
US public health authorities
CIDRAP and Dr Andrew Racine, president of the American Academy of Pediatrics, call 2026's 2,318 confirmed measles cases by 24 July the worst year since 1991's 2,126. Zero deaths against three in 2025 and a 7% hospitalisation rate, down from 11%, show record case counts have not brought record severity.
CEPI
CEPI
CEPI put an rVSV-platform vaccine candidate specific to Bundibugyo ebolavirus into trial-production on 31 July, developed by Hilleman Laboratories with MSD manufacturing and IAVI's reference virus, funded up to $8.5m. Eleven weeks into the third-largest Ebola outbreak on record, this is the first species-matched candidate; the licensed vaccine covers only Zaire ebolavirus.
Médecins Sans Frontières
Médecins Sans Frontières
MSF reports sexual-violence care in Ituri is almost non-existent, with 7 of 14 health centres closed or relocated by fighting, as Panzi Hospital logs 646 new survivors in six months, an 85% rise. Withdrawn US funding for post-exposure prophylaxis has left clinics across three provinces without PEP kits for months, a crisis running alongside Ebola, not caused by it.
DRC health workers at Elikya Ebola Treatment Centre
DRC health workers at Elikya Ebola Treatment Centre
Staff at DRC's Elikya Ebola Treatment Centre walked out on 25 July over unpaid wages, the second such action after Rwampara, while unconfirmed suspects occupy up to 64% of the country's isolation beds awaiting lab results. Workers are absorbing a response that has grown faster than its payroll and its labs.
Uganda's Ministry of Health
Uganda's Ministry of Health
Uganda's ministry says it discharged its last confirmed patient on 16 June, completed every contact's 21-day follow-up, and declared the country Ebola-free on 28 July, exactly 42 days later. It names Hon. Dr Chris Baryomunsi, Minister of Health, as overseeing a 20-case, 2-death outbreak it now considers closed.